
Now that Regeneron Pharmaceuticals, Inc’s volume has hit 1.0 million, investors get a glimpse of its size.
Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) on Tuesday, plunged -3.97% from the previous trading day, before settling in for the closing price of $570.59. Within the